Abstract
This article describes the causes and outcomes of dilated cardiomyopathy in children. Genetic, infectious, metabolic, and acquired causes of dilated cardiomyopathy are discussed. The predictors for better and worse outcomes are reviewed. Guidelines for the use of medical and surgical therapies to treat heart failure in children are summarized.
Copyright © 2010 Elsevier Inc. All rights reserved.
MeSH terms
-
Cardiomyopathy, Dilated / diagnosis
-
Cardiomyopathy, Dilated / epidemiology
-
Cardiomyopathy, Dilated / etiology*
-
Cardiomyopathy, Dilated / therapy*
-
Cardiotonic Agents / therapeutic use
-
Child
-
Defibrillators, Implantable
-
Genetic Predisposition to Disease
-
Heart Failure / classification
-
Heart Failure / etiology
-
Heart Failure / mortality
-
Heart Failure / therapy*
-
Heart Transplantation
-
Heart-Assist Devices
-
Humans
-
Metabolism, Inborn Errors / complications
-
Mitral Valve / surgery
-
Mitral Valve Insufficiency / surgery
-
Myocarditis / complications
-
Myocarditis / diagnosis
-
Pacemaker, Artificial
-
Phenotype
-
Prognosis